Alex Denner’s Sarissa Capital Management recently disclosed its stock picks for the fourth quarter of 2014 in a 13F …
Sarissa
Ariad stock will be in the penalty box pending better clarity on how this increased safety risk will affect current utilization,” Michael Yee, an analyst with RBC Capital Markets, wrote in a note today. Iclusig was approved based on an …
Ariad Pharmaceuticals Inc. stock climbed sharply for the second consecutive day Friday on market speculation that the Cambridge biotechnology company is a takeover target. Shares of Ariad closed up $1.47 to $8.99, gaining 19.5 …
The Company gained 12.71% and finished at $9.49. The daily volume was measured at 15.89 million shares. The 52-week high of the share price is $10.07 and the 52-week low is $4.37. The company has a market cap of $1.59 billion. Its …
In a report issued 11/03/2016 Deutsche Bank increased the stock price target of Ariad Pharmaceuticals …
Cambridge, MA-based Ariad Pharmaceuticals’ (NASDAQ:ARIA) stock is up more than 25 percent this morning. It’s to be expected; the firm is reporting today that its top cancer drug candidate, which the drug giant Merck (NYSE:MRK) is …
I'm a new Aria user, and I've pretty much got everything setup for Exchange access via ActiveSync. I am able to set the stock HTC e-mail client to receive HTML formatted messages from our Exchange server, which is great. However, I get …
Do not stay at the Aria Resort and Casino. It's a rip-off ... plus the invaluable Crotty on Education Stock Index. You can subscribe to Crotty Newsletters here.
Las Vegas
Shares of Ariad Pharmaceuticals Inc. (NASDAQ: ARIA) were down handily on Monday. The drop follows news that JPMorgan downgraded the stock to Underweight from Neutral. The firm also set a $7 price target. What investors will …
Wall Street
The stock was sold at an average price of $23.78 ... The original version of this story can be read at https://www.chaffeybreeze.com/2017/02/28/ariad-pharmaceuticals-inc-aria-receives-15-56-average-target-price-from …
Breeze2mon